Collegium Pharmaceutical
COLL
159 hedge funds and large institutions have $603M invested in Collegium Pharmaceutical in 2020 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 48 increasing their positions, 50 reducing their positions, and 21 closing their positions.
110% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 21
24% more call options, than puts
Call options by funds: $1.47M | Put options by funds: $1.19M
15% more funds holding
Funds holding: 138 → 159 (+21)
13.88% more ownership
Funds ownership: 93.98% → 107.86% (+14%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 50
7% less capital invested
Capital invested by funds: $649M → $603M (-$45.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$41.3M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$25M |
| 3 |
PA
Perceptive Advisors
New York
|
+$23.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$14M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$12.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$19.5M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$8.26M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$6.47M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3.76M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$3.36M |
COLL Hedge Fund Activity: Q1 2020 in Review
159 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q1 2020, worth a combined $603M — down 7% from $649M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new COLL positions and 21 closed out — a net gain of 23 holders — while 48 added to existing stakes and 50 trimmed.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $41.3M. The largest seller was Frazier Management, cutting an estimated $19.5M.
- 159 institutional investors held Collegium Pharmaceutical (COLL) as of Q1 2020, up from 138 in Q4 2019.
- Funds reported $603M of Collegium Pharmaceutical stock for Q1 2020, down 7% quarter-over-quarter.
- 44 funds opened new Collegium Pharmaceutical positions in Q1 2020 and 21 closed out, a net change of +23 holders.
- The largest Collegium Pharmaceutical buyer in Q1 2020 was Camber Capital Management, an estimated $41.3M added.
- The largest Collegium Pharmaceutical seller in Q1 2020 was Frazier Management, an estimated $19.5M sold.
Based on aggregated 13F filings for Q1 2020.